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N E W S L E T T E R
UNIVERSITY OF MALAYA JOIN
COVID-19 TESTING BATTLE
Recently, diagnostic laboratories at public
universities have been appointed to help the
Ministry of Health in conducting 16,500
Covid-19 tests daily.
 
Prof. Dr. Sazaly Abu Bakar, the director of
UM's Tropical Infectious Diseases Research
and Education Centre (TIDREC) in addressing
the pandemic, commented that universities
can contribute beyond diagnostic testing. 
 
TIDREC is the only national Higher Institution
Centre of Excellence for infectious diseases.
It houses the World Health Organisation’s
(WHO) Collaborating Centre for Arbovirus
Reference and Research. 
 
With extensive experience in research in
tropical    infectious   diseases,   especially   in
arthropod-borne and emerging virulent
pathogens, TIDREC can contribute in a
meaningful way to the Health Ministry.
TIDREC is equipped with the necessary
instruments, biosafety protective equipment
and the reagents, needed to carry out the
testing.  The facility is equipped to handle
highly virulent pathogens, including the
SARS-CoV-2 virus, the agent that causes
Covid-19. 
 
TIDREC has been involved in the
development of anti-viral agents for dengue,
chikungunya and Zika in collaboration with
WHO for many years. Covid-19 may be a
different virus, but all we have to do is
develop a new set of protocols,” said Prof. Dr.
Sazaly, adding that TIDREC offers to test 100
samples a day for this initiative.
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One of the main ways medical workers get
infected with the Covid-19 virus is when they
come into close contact with infected
patients while examining and administering
breathing support machine to the patients.
 
Responding to the rising needs of doctors to
prevent infection while treating patients,
researchers from the UM Centre for
Innovation in Medical Engineering (CIME)
have taken the initiative to fabricate 54
intubation protective boxes (based on Lai's
design) produced using 3D printing
technology for our frontliners.
 
The innovative protective box named the
‘aerosol box’ was created by Lai Hsien-yung,
an anesthesiologist with the Mennonite
Christian Hospital in Hualien, Taiwan. The
invention is able to help physicians perform
endotracheal intubations safely on infected
patients as it acts as a barrier between the
doctor and infected patient.
Prof. Dr. Fatimah Ibrahim, the founder and
advisor for CIME said the boxes were given to
frontline healthcare personnel at UM Medical
Centre (UMMC). The boxes were also
delivered to hospitals in Sungai Buloh, Klang,
Shah Alam, and Melaka. 
 
CIME has been granted seed funding by the
varsity to improve on the current design by
incorporating more safety and ergonomic
features to the box. 
 
CIME has also assisted in obtaining the
Medical Device Authority (MDA) exemption to
bring in Real-time Polymerase Chain
Reaction Covid-19 test kits for non-
commercial use. The test kits will help ease
the burden of laboratories that are running
out of reagents to conduct tests. It will also
save lab technicians’ time as these kits allow
them to do tests without the hassle of having
to replicate new components for every
patient.
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SUPPORTING OUR FRONTLINERS
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A group of researchers at UM has developed
the Covid Symptom Monitoring System
(CoSMoS) to help medical staff monitor
patients suspected of Covid-19 infection.The
system has already been used at the
Universiti Malaya Medical Centre (UMMC) to
monitor individuals suspected of having
contracted Covid-19 and those in home
quarantine, and is expected to also be of use
in monitoring medical teams exposed to
Covid-19 patients.
 
CoSMoS is 100 percent produced by UM
using a public messaging engine, artificial
intelligence and web technology. It was
developed by a team of Malaysian computer
scientists at the faculty.
 
Currently, a large number of medical staff
monitor these patients by making routine
calls to them or visiting them at home.
Through the CoSMoS application, the
monitoring process will be automated and
patients can insert their daily symptoms into
CoSMoS, which would be transmitted to the
CoSMoS primary system at UMMC where
doctors can access real-time information
through dashboards.
Through this system, medical staff would
have have to make calls to only 10 percent of
patients in need of supervision, while the rest
could be monitored through CoSMoS, thus
allowing 80-90 percent of medical staff to
perform other tasks such as contact tracing
and screening.
 
CoSMoS would change the management of
patients suspected of being infected with
Covid-19 who are quarantined at home.
CoSMoS also leverages existing technology
to make it accessible to the majority of the
community,
 
Datuk Prof. Dr. Adeeba Kamarulzaman, Dean
of the Faculty of Medicine, who is also
chairman of the UMMC Covid-19 Working
Group, said CoSMoS – developed in eight
days through a collaboration with Malaysian
researchers in various countries – is still
undergoing pilot testing at UMMC but has
already received approval from the
university’s Medical Research Ethics
Committee. All patients using CoSMoS have
given their consent for their data to be used
for clinical research and monitoring
purposes. 
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COSMOS: 
UM DEVELOPS APP TO MONITOR
SUSPECTED COVID-19 PATIENTS
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PRODUCING HAND SANITISERS IN
UM LAB
A group of researchers from Centre for
Natural Products Research and Drug
Discovery (CENAR), UM and Mr. Murali Prasad
Y. Vandayar, Country Lead, The US State
Department’s Global Innovation Through
Science and Technology (GIST) Movement
collaborated to produce hand sanitiser
following the difficulty in procuring the
product in the market.
 
These hand sanitisers are produced using a
simple dilution process. Denatured
pharmaceutical grade ethanol is diluted and
added to a few other compounds. There are
several universities producing these hand
sanitisers in labs according to their
laboratory capacity. UM, for instance, can
produce up to 75 litres a day.
 
The idea is to set up a temporary hand
sanitiser production facility in the campus.
These hand sanitisers will then be
distributed to areas outside the university
and to high-risk areas near the university
such as petrol stations, drive-throughs and
restaurants.
